GILEAD SCIENCES, INC. Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation
GILEAD SCIENCES, INC. (GILD) reported Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation of 2.00 million shares for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-03.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation · last filed 2023-05-03
- GILEAD SCIENCES, INC. share-based payment arrangement, shares withheld for tax withholding obligation for the quarter ending 2023-03-31 was 2.00M shares.
| Period end | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation 3 month |
|---|---|
| 2023-03-31 | 2.00M shares 10-Q · filed 2023-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |